Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
I think we are seeing a lot more strategic alliances and partnering of early stage companies simply because it's so expensive to put a drug through clinical trials and a lot of companies when evaluating their opportunities, as I mentioned earlier, realize that you know, you really have to consider w...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
